| Product Code: ETC8277470 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Drug Discovery Outsourcing Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Drug Discovery Outsourcing Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Drug Discovery Outsourcing Market - Industry Life Cycle |
3.4 Mexico Drug Discovery Outsourcing Market - Porter's Five Forces |
3.5 Mexico Drug Discovery Outsourcing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Mexico Drug Discovery Outsourcing Market Revenues & Volume Share, By Drug Molecule, 2021 & 2031F |
3.7 Mexico Drug Discovery Outsourcing Market Revenues & Volume Share, By Discovery Approach, 2021 & 2031F |
3.8 Mexico Drug Discovery Outsourcing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Mexico Drug Discovery Outsourcing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Mexico Drug Discovery Outsourcing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Mexico Drug Discovery Outsourcing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for cost-effective drug discovery services |
4.2.2 Growing trend of outsourcing in pharmaceutical industry |
4.2.3 Advancements in technology and expertise in drug discovery processes |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment impacting outsourcing decisions |
4.3.2 Concerns regarding data security and intellectual property protection |
5 Mexico Drug Discovery Outsourcing Market Trends |
6 Mexico Drug Discovery Outsourcing Market, By Types |
6.1 Mexico Drug Discovery Outsourcing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Chemical Services, 2021- 2031F |
6.1.4 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Biology Services, 2021- 2031F |
6.2 Mexico Drug Discovery Outsourcing Market, By Drug Molecule |
6.2.1 Overview and Analysis |
6.2.2 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Small Molecules, 2021- 2031F |
6.2.3 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Large Molecules, 2021- 2031F |
6.3 Mexico Drug Discovery Outsourcing Market, By Discovery Approach |
6.3.1 Overview and Analysis |
6.3.2 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Empirical Drug Discovery, 2021- 2031F |
6.3.3 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Rational Drug Discovery, 2021- 2031F |
6.4 Mexico Drug Discovery Outsourcing Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Target Identification and Screening, 2021- 2031F |
6.4.3 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Lead Identification and Candidate Optimization, 2021- 2031F |
6.4.4 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Development of Disease Models, 2021- 2031F |
6.4.5 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Pre-formulation Studies, 2021- 2031F |
6.4.6 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Entire Clinical Trials, 2021- 2031F |
6.4.7 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Mexico Drug Discovery Outsourcing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Anti-infective, 2021- 2031F |
6.5.3 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.5.4 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Central Nervous System, 2021- 2031F |
6.5.5 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Dermatology, 2021- 2031F |
6.5.6 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Endocrine, 2021- 2031F |
6.5.7 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Gastrointestinal, 2021- 2031F |
6.5.8 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Mexico Drug Discovery Outsourcing Market, By End-user |
6.6.1 Overview and Analysis |
6.6.2 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.6.3 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Biotechnology Companies, 2021- 2031F |
6.6.4 Mexico Drug Discovery Outsourcing Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
7 Mexico Drug Discovery Outsourcing Market Import-Export Trade Statistics |
7.1 Mexico Drug Discovery Outsourcing Market Export to Major Countries |
7.2 Mexico Drug Discovery Outsourcing Market Imports from Major Countries |
8 Mexico Drug Discovery Outsourcing Market Key Performance Indicators |
8.1 Percentage of growth in the number of drug discovery outsourcing contracts in Mexico |
8.2 Average turnaround time for drug discovery projects |
8.3 Number of successful drug discoveries attributed to outsourcing partnerships |
8.4 Percentage increase in research and development investment by pharmaceutical companies in Mexico |
8.5 Customer satisfaction scores from pharmaceutical companies outsourcing drug discovery projects |
9 Mexico Drug Discovery Outsourcing Market - Opportunity Assessment |
9.1 Mexico Drug Discovery Outsourcing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Mexico Drug Discovery Outsourcing Market Opportunity Assessment, By Drug Molecule, 2021 & 2031F |
9.3 Mexico Drug Discovery Outsourcing Market Opportunity Assessment, By Discovery Approach, 2021 & 2031F |
9.4 Mexico Drug Discovery Outsourcing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Mexico Drug Discovery Outsourcing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Mexico Drug Discovery Outsourcing Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Mexico Drug Discovery Outsourcing Market - Competitive Landscape |
10.1 Mexico Drug Discovery Outsourcing Market Revenue Share, By Companies, 2024 |
10.2 Mexico Drug Discovery Outsourcing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here